Combination Therapy Using Low-Concentration Oxacillin with Palmitic Acid and Span85 to Control Clinical...

Area of Science:

• Microbiology
• Infectious Diseases
• Pharmacology

Background:

• Antibiotic overuse has driven the rise of multidrug-resistant bacteria, notably methicillin-resistant Staphylococcus aureus (MRSA).
• MRSA's resistance mechanisms include increased PBP2a expression, biofilm formation, SCCmec acquisition, and altered membrane properties, complicating treatment with single agents.
• Overcoming resistance necessitates innovative therapeutic approaches, such as drug combination therapy.

Purpose of the Study:

• To investigate synergistic drug combinations for combating MRSA.
• To determine the optimal ratio of components for effective MRSA control.
• To evaluate the efficacy of these combinations against diverse clinical MRSA isolates.

Main Methods:

• Investigated synergistic effects of drug combinations, including oxacillin, free fatty acids, and surfactants.
• Tested combinations against clinically isolated MRSA strains with varying SCCmec types.
• Analyzed phospholipid profiles of resistant strains to understand resistance mechanisms.

Main Results:

• A combination therapy containing 15 μg/mL oxacillin effectively controlled SCCmec types III and IV MRSA isolates with high oxacillin minimum inhibitory concentrations (MICs).
• Slightly increased oxacillin concentrations in the combination eradicated SCCmec type II MRSA.
• Phospholipid analysis indicated that higher resistance correlated with increased anteiso-C15:0 and anteiso-C17:0 fatty acids in clinical strains.

Conclusions:

• Combinatorial therapy with low-dose oxacillin demonstrates significant efficacy against diverse laboratory and clinical MRSA strains.
• This approach offers a promising strategy to overcome antibiotic resistance and reduce the potential for further genetic mutations.
• Understanding lipid profiles may provide insights into MRSA resistance mechanisms and guide future therapeutic development.